NGT Plant Products in the EU. The Postulates, The Outlooks, and Possible Consequences of a Regulatory System Reform in the Context of Legislative Reforms in Third Countries and Detection Requirements

Abstract

AbstractThis chapter presents potential consequences of the adoption of strict detection, identification or traceability requirements in the EU legislation regarding NGT products featuring single nucleotide variants. The context considered encompasses changes in the biosafety legislations not only in countries which were traditionally accepting of modern biotechnology products, but also in countries which were reluctant to use classic GMOs. Due to shifts in the approach to the regulation of NGT products not featuring stable inserts of foreign DNA, the EU risks becoming an isolated market with provisions not harmonized with those of its various trade partners or falling into a situation where regulated products officially not present on the market will enter due to a lack of efficient detection and identification methods and enforcement systems. Recent changes in the laws of such countries as Nigeria, Kenya or Japan are presented, as well as the recent jurisprudence of the Court of Justice of the EU.